Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
RON fluctuated 83.5% within 24 hours: price surged from $0.085 to $0.156, mainly driven by market trading

RON fluctuated 83.5% within 24 hours: price surged from $0.085 to $0.156, mainly driven by market trading

Bitget PulseBitget Pulse2026/05/19 00:17
Show original
By:Bitget Pulse

Volatility Overview

In the past 24 hours, the price of RON surged rapidly from a low of $0.085 to a high of $0.156 before retracing to $0.1218, representing an overall amplitude of 83.5%. The price exhibited strong volatility, with the peak price approximately 28% higher than the current level and the lowest point about 30% below the current price.

Brief Analysis of the Cause of Abnormal Fluctuation

- No official announcements from Ronin, major on-chain events, or direct reports by mainstream media were detected in the past 24 hours.

- The previously completed Ethereum L2 migration (on May 12) and the Tokenomics adjustment that reduced RON inflation by 89% (annual inflation rate dropped from above 20% to below 1%) remain key focus points for the market and may indirectly influence short-term trading sentiment.

- The sharp price fluctuations are mainly linked to active market trading. As of now, there is no publicly available on-chain data to verify specifics regarding capital inflow/outflow and whale address movements.

Market Opinions and Outlook

The community and analysts have taken a cautious and wait-and-see attitude toward RON's short-term trend. Some opinions suggest that the improved security and deflationary effect brought by the L2 migration will provide long-term support, but also warn of the risk of high volatility and macro market corrections in the short term. Mainstream forecasts emphasize that future performance will depend on the actual adoption rate of the Ethereum L2 ecosystem and the recovery of on-chain activity.

Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for information reference only.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify

In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.

华尔街见闻•2026/11/06 15:01

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23